SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 2,026.74 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 330,105.00 |
| Book Value / Share | 3,967.99 |
| Price / Book | n/a |
| NCAV ($M) | 161,434.00 |
| NCAV / Share | 2,131.49 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.08 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.11 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.62 |
| Current Ratio | 4.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 295,709.00 |
| Assets | 464,380.00 |
| Liabilities | 134,275.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 181,093.00 |
| Operating Income | 40,126.00 |
| Net Income | 32,428.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 33,823.00 |
| Cash from Investing | -24,974.00 |
| Cash from Financing | -19,871.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| TRGM – Targeted Medical Pharma, Inc. | TRGNF – Transgene SA |
| TRVN – Trevena, Inc. | UCBJF – UCB SA |
| UNBSF – Uni-Bio Science Group Limited |
Financial data and stock pages provided by
Fintel.io